logo

Bausch Health Companies Inc. (BHC.TO)



Trade BHC.TO now with
  Date
  Headline
5/27/2020 7:25:36 AM Bausch + Lomb Reports European Launch Of LuxSmart And LuxGood Preloaded Intraocular Lenses
5/27/2020 7:03:26 AM Bausch + Lomb Announces European Launch Of LuxSmart And LuxGood Preloaded Intraocular Lenses
5/11/2020 7:11:02 AM Bausch Health Launches $1.25 Bln Private Offering Of Senior Notes Due 2029
5/7/2020 7:18:04 AM Bausch Health Companies Q1 Net Loss $152 Mln Vs. Net Loss $52 Mln Last Year
4/29/2020 7:10:55 AM Bausch Health Companies Says FDA OKs JUBLIA Topical Solution, 10%, In Patients As Young As Six Years Old
4/13/2020 7:06:58 AM Bausch Health Initiates VIRAZOLE Clinical Study In Patients With COVID-19
3/31/2020 7:07:57 AM Bausch Health Announces Favorable Topline Results FromPhase 2 Study Of Rifaximin SSD IR
3/13/2020 7:03:53 AM Bausch Health To Reduce Debt By About $100 Mln Using Cash Generated From Operations
1/28/2020 7:20:14 AM Bausch Health And Clearside Biomedical Announce Publication Of PIVOTAL Phase 3 Data ON XIPERETM In Ophthalmology
1/13/2020 6:50:22 AM Ortho Dermatologics Publishes Pivotal Phase 3 Data On ARAZLO Lotion, 0.045% In The Journal Of Drugs In Dermatology
1/6/2020 8:30:30 AM Bausch + Lomb Unveils Expanded Parameters For Biotrue ONEday For Astigmatism Daily Disposable Contact Lenses
12/20/2019 8:31:33 AM Bausch Health Licenses Novaliq' NOV03 Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunc
12/20/2019 6:49:10 AM Bausch Health Announces Resolution Of BRYHALI Lotion, 0.01%, Intellectual Property Litigation With Glenmark
12/19/2019 7:00:39 AM Bausch Health Companies: FDA Approves NDA For ARAZLOTM Lotion, 0.045%
12/17/2019 8:33:11 AM Bausch + Lomb Begins Clinical Trial On New Cohesive Ophthalmic Viscosurgical Device For Use In Cataract Surgery
12/17/2019 7:16:22 AM Bausch Health Companies Launches Private Offering Of Senior Notes
12/11/2019 8:31:52 AM Bausch + Lomb Unveils EnVista Toric MX60ET Intraocular Lens With StableFlex Technology